Trial Profile
Second placebo-controlled trial of benznidazole evaluating safety and efficacy in Pediatric patients 6 to 12 years old with Chagas disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Jan 2018
Price :
$35
*
At a glance
- Drugs Benznidazole (Primary)
- Indications Chagas disease
- Focus Therapeutic Use
- 07 Sep 2017 New trial record
- 29 Aug 2017 Based on the data from this and other trial (see profile 288390), the U.S. Food and Drug Administration has granted accelerated approval to benznidazole for use in children ages 2 to 12 years old with Chagas disease, as reported in a FDA media release.
- 29 Aug 2017 Results published in the FDA Media Release